Maze Therapeutics, Inc. (MAZE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 379.78M | 349.72M | 391.3M | 271.15M | 299.71M | 201.67M | 153.96M | 179.4M | 34.11M |
| Cash & Short-Term Investments | 352.38M | 341.92M | 383.94M | 264.54M | 294.37M | 196.81M | 149.61M | 175.06M | 29.16M |
| Cash Only | 198.77M | 189.25M | 316.77M | 264.54M | 294.37M | 196.81M | 149.61M | 175.06M | 29.16M |
| Short-Term Investments | 153.62M | 152.67M | 67.16M | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 20M | 0 | 700K | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | 90 | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 7.4M | 7.8M | 6.67M | 6.61M | 5.33M | 4.86M | 4.35M | 4.33M | 4.95M |
| Total Non-Current Assets | 39.93M | 47.41M | 30.76M | 32.37M | 33.13M | 38.87M | 38.52M | 36.4M | 37.39M |
| Property, Plant & Equipment | 23.97M | 25.16M | 26.46M | 27.71M | 28.8M | 29.92M | 30.93M | 32.16M | 34.98M |
| Fixed Asset Turnover | 0.81x | - | - | - | - | - | 0.08x | 4.91x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 18.11M | 1.09M | 1.09M | 1.09M | 1.09M | 1.09M | 0 | 1.09M |
| Other Non-Current Assets | 15.96M | 4.14M | 3.21M | 3.57M | 3.25M | 7.87M | 6.5M | 4.23M | 1.32M |
| Total Assets | 419.71M | 397.13M | 422.06M | 303.52M | 332.84M | 240.54M | 192.48M | 215.79M | 71.5M |
| Asset Turnover | 0.05x | - | - | - | - | - | 0.01x | 1.15x | - |
| Asset Growth % | 26.1% | 65.1% | 119.27% | 40.65% | - | 236.4% | - | - | - |
| Total Current Liabilities | 21.24M | 22.56M | 22.11M | 19.9M | 18.62M | 20.67M | 17.55M | 21.61M | 16.32M |
| Accounts Payable | 4.01M | 1.79M | 2.92M | 3.67M | 2.4M | 1.94M | 1.02M | 2.18M | 2.02M |
| Days Payables Outstanding | 588.55 | 434.37 | - | 425.55 | - | - | - | - | - |
| Short-Term Debt | 4.84M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.5M | 0 |
| Other Current Liabilities | 12.38M | 10.85M | 6.24M | 5.84M | 7.26M | 6.02M | 5.49M | 4.47M | 2.93M |
| Current Ratio | 17.88x | 15.50x | 17.70x | 13.63x | 16.10x | 9.76x | 8.77x | 8.30x | 2.09x |
| Quick Ratio | 17.88x | 15.50x | 17.70x | 13.63x | 16.10x | 9.76x | 8.77x | 8.30x | 2.09x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 56.77M | 19.61M | 20.51M | 21.38M | 22.15M | 22.96M | 75.56M | 456.56M | 45.13M |
| Long-Term Debt | 38.83M | 0 | 0 | 0 | 0 | 0 | 51.75M | 49.1M | 20.08M |
| Capital Lease Obligations | 17.55M | 18.51M | 19.42M | 20.29M | 21.15M | 22M | 22.8M | 23.56M | 25.05M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 388K | 1.09M | 1.09M | 1.09M | 1.01M | 969K | 1.01M | 383.9M | 0 |
| Total Liabilities | 78.01M | 42.16M | 42.62M | 41.28M | 40.77M | 43.64M | 93.11M | 478.17M | 61.45M |
| Total Debt | 61.22M | 23.31M | 24.18M | 25.01M | 25.82M | 26.63M | 79.16M | 77.23M | 49.62M |
| Net Debt | -137.54M | -165.94M | -292.59M | -239.53M | -268.55M | -170.18M | -70.45M | -97.83M | 20.46M |
| Debt / Equity | 0.18x | 0.07x | 0.06x | 0.10x | 0.09x | 0.14x | 0.80x | - | 4.94x |
| Debt / EBITDA | - | - | - | - | - | - | - | 0.55x | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -0.70x | - |
| Interest Coverage | -30.66x | - | - | - | - | - | - | - | - |
| Total Equity | 341.7M | 354.97M | 379.44M | 262.24M | 292.07M | 196.9M | 99.37M | -262.37M | 10.05M |
| Equity Growth % | 16.99% | 80.27% | 281.84% | 199.95% | - | 1858.46% | - | - | - |
| Book Value per Share | 6.34 | 8.26 | 8.29 | 5.98 | 6.67 | 4.50 | 2.27 | -5.99 | 0.23 |
| Total Shareholders' Equity | 341.7M | 354.97M | 379.44M | 262.24M | 292.07M | 196.9M | 99.37M | -262.37M | 10.05M |
| Common Stock | 50K | 49K | 48K | 44K | 44K | 2K | 23K | 23K | 2K |
| Retained Earnings | -513.75M | -489.55M | -454.98M | -424.89M | -391.21M | -358.43M | -313.88M | -289.12M | -395.69M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -135K | 110K | 69K | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |